# Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

> **NCT07683585** · NA · RECRUITING · sponsor: **National Medical Research Center for Therapy and Preventive Medicine** · enrollment: 207 (estimated)

## Conditions studied

- Hypertension
- Coronary Arterial Disease
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Losartan + Hydrochlorothiazide
- **DRUG:** Amlodipine + Azilsartan

## Key facts

- **NCT ID:** NCT07683585
- **Lead sponsor:** National Medical Research Center for Therapy and Preventive Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 207 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07683585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07683585, "Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07683585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*